Name: Takeda Pharmaceutical Company Limited (TAK) Balance Sheet
Creator: FinSpry

Takeda Pharmaceutical Company Balance Sheet Analysis

Assets, liabilities, and stockholders equity in trillions JPY

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Takeda Pharmaceutical Company Limited (TAK) - Annual data in trillions JPY
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 2025	Dec 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Current Assets
Cash and Cash Equivalents	0.39	0.39	0.46	0.63	0.95	1.00	0.65	0.73
Short-Term Investments	0.02	0.02	0.02	0.03	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	0.41	0.41	0.46	0.63	0.95	1.00	0.65	0.73
Accounts Receivable	0.77	0.73	0.70	0.68	0.72	0.81	0.78	0.75
Inventory	1.22	1.22	1.21	0.99	0.85	0.75	0.76	0.92
Other Current Assets	0.16	0.17	0.19	0.18	0.14	0.12	0.11	0.11
Total Current Assets	2.52	2.52	2.56	2.48	2.66	2.71	2.47	2.99
Non-Current Assets
Property, Plant & Equipment (Net)	1.97	1.97	1.99	1.69	1.58	1.45	1.39	1.33
Long-Term Investments	0.01	0.36	0.10	0.10	0.11	0.00	0.00	0.00
Goodwill	5.32	5.32	4.79	4.41	4.03	0.00	0.00	0.00
Intangible Assets	3.63	3.63	4.27	3.82	3.91	0.00	0.00	0.00
Other Non-Current Assets	0.07	0.07	0.05	0.06	0.08	0.10	0.10	0.09
Total Non-Current Assets	11.73	11.73	12.55	11.48	10.51	10.20	10.35	10.80
Total Assets	14.25	14.25	15.11	13.96	13.18	12.91	12.82	13.79
Current Liabilities
Accounts Payable	0.31	0.31	1.29	0.91	0.74	0.49	0.50	0.48
Short-Term Debt	0.55	0.55	0.34	0.20	0.02	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.20	0.05	0.30	0.20	0.02	0.00	0.00	0.00
Other Current Liabilities	0.82	1.65	-0.04	0.75	0.78	0.79	0.68	0.70
Total Current Liabilities	2.51	2.51	2.31	2.78	2.62	1.77	2.18	2.55
Non-Current Liabilities
Long-Term Debt	3.97	3.97	4.48	4.04	4.14	4.61	4.51	4.77
Deferred Tax Liabilities	0.04	0.04	0.27	0.45	0.54	0.00	0.00	0.00
Other Non-Current Liabilities	0.63	0.80	0.91	2.28	2.21	0.57	0.45	0.31
Total Non-Current Liabilities	4.81	4.81	5.52	6.50	6.55	5.96	5.92	6.05
Total Liabilities	7.31	7.31	7.83	9.28	9.17	7.74	8.09	8.61
Stockholders' Equity
Common Stock	1.69	1.69	1.68	1.68	1.67	0.00	0.00	0.00
Retained Earnings	1.19	1.19	1.39	1.54	1.48	1.51	1.37	1.60
Accumulated Other Comprehensive Income	2.35	2.51	1.51	0.93	0.37	0.00	0.00	0.08
Treasury Stock	0.07	0.05	-0.05	-0.10	-0.12	-0.06	-0.09	-0.06
Additional Paid-in Capital	1.78	1.75	4.26	1.73	1.71	1.69	1.68	1.65
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Shares Outstanding	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Stockholders' Equity	6.94	6.94	7.27	4.68	4.01	5.18	4.73	5.19
Total Liabilities & Equity	14.25	14.25	15.11	13.96	13.18	12.91	12.82	13.79